Stock Quality:
ADMA RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Last 7 days
-6.1%
Last 30 days
42.0%
Last 90 days
55.3%
Trailing 12 Months
321.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 283.2M | 330.2M | 0 | 0 |
2023 | 181.9M | 208.1M | 234.3M | 258.2M |
2022 | 122.6M | 138.7M | 159.1M | 154.1M |
2021 | 48.1M | 58.1M | 68.5M | 109.6M |
2020 | 36.2M | 37.0M | 40.1M | 42.2M |
2019 | 16.5M | 18.8M | 21.8M | 29.6M |
2018 | 24.2M | 25.4M | 24.9M | 17.0M |
2017 | 11.2M | 12.3M | 14.1M | 22.8M |
2016 | 7.8M | 8.8M | 9.8M | 10.7M |
2015 | 5.9M | 5.7M | 6.2M | 7.2M |
2014 | 3.8M | 4.6M | 4.9M | 5.9M |
2013 | 1.9M | 2.4M | 3.2M | 3.1M |
2012 | 1.7M | 1.5M | 1.3M | 1.1M |
2011 | 0 | 0 | 0 | 1.9M |
2010 | 0 | 0 | 0 | 0 |
CEO | Mr. Adam S. Grossman |
---|---|
WEBSITE | admabiologics.com |
INDUSTRY | Biotechnology |
EMPLOYEES | 617 |